Stelo vs Lingo: Which OTC CGM Is Worth It?

Updated June 30, 2026

Data as of 2026-06-01. Informational only — consult your healthcare provider before making decisions based on continuous glucose monitor (CGM) data.

Two over-the-counter CGMs now sit on the same drugstore shelf, and they answer fundamentally different questions. Stelo tells you where your glucose is trending over weeks. Lingo tells you what your breakfast just did in the last sixty seconds. Picking the wrong one is the difference between a useful habit and an expensive distraction.

Key Takeaways

• Best overall (and best for prediabetes): Stelo — slightly better published accuracy (Mean Absolute Relative Difference, or MARD, of 8.3%), longer 15-day wear time, and an app designed for trend-watching rather than chasing numbers. - Best for athletes and performance trackers: Lingo — readings every 1 minute (versus Stelo's 15) make it the only realistic choice for capturing workout and meal-response spikes. - Best for trying a CGM once: Lingo's $49 single-sensor "Start" pack — the cheapest over-the-counter (OTC) entry point in the U.S. - Cheapest long-term: Lingo's $249 six-pack at roughly $2.96 per day, which quietly undercuts Lingo's own subscription tier. Both monitors are health savings account (HSA) and flexible spending account (FSA) eligible.

Comparison Table

Prices: stelo.com, hellolingo.com. Accuracy: ImproveBiomarkers CGM comparison.

That tradeoff — resolution versus disclosed accuracy — is the real story. Most spec-sheet comparisons stop at the numbers; the choice that actually matters is which app, ecosystem, and data cadence fits the question you're asking. "How does my morning oatmeal move my glucose?" is a Lingo question. "Am I trending toward prediabetes over the next 90 days?" is a Stelo question.

Best For Picks

Best overall: Stelo. Better published accuracy, an extra day of wear per sensor, and an app built around trend lines instead of moment-to-moment numbers. For 90% of buyers — anyone curious about how food, sleep, or stress moves their glucose — this is the calmer, more useful device.

Best budget: Lingo's $49 single-sensor "Start" kit. It's the cheapest entry point in the OTC CGM market (hellolingo.com). Fourteen days of data for less than the cost of a gym membership. If you're not sure you'll wear one for more than two weeks, start here.

Best for athletes and meal-response tracking: Lingo. A 15-minute lag on Stelo means you won't see the actual peak of a glucose spike from a hard interval session or a high-carb meal — by the time the next reading hits, the curve has already moved. Lingo's one-minute cadence captures the shape of the spike, which is the whole point if you're tuning fueling, fasted training, or post-workout recovery.

Stelo by Dexcom

Stelo was the first FDA-cleared OTC CGM in the U.S., landing in March 2024 and beating Lingo to market by roughly three months. An OTC CGM is a sensor you can buy without a prescription — it sits on the back of your upper arm for two weeks and sends glucose readings to your phone ((Fierce Biotech)). Dexcom built it on the same biosensor platform as its prescription G7, then stripped out the alarms and dosing features that require a physician.

The positioning is medical-adjacent: Stelo is aimed at adults with type 2 diabetes not on insulin and people with prediabetes who want to see how lifestyle changes move their numbers ((MedTech Dive)). The app reflects that — it surfaces daily averages, time-in-range, and weekly trend reports rather than spike-by-spike granularity.

Pros
- Higher published accuracy (8.3% MARD) with a stated 93% lab-comparison agreement, per Dexcom's FDA 510(k) submission (clearance K233969) summarized at stelo.com
- 15-day wear, one day longer than Lingo
- Strong PDF export for sharing with a doctor — the report format mirrors clinical CGM reports
- Backed by Dexcom's prescription CGM infrastructure and support

Cons
- 15-minute reading interval — too slow for capturing acute workout or meal spikes
- No one-time pricing below the 2-pack ($99 minimum entry)
- App is more clinical than consumer — fewer gamified insights than Lingo

Lingo by Abbott

Abbott followed Stelo to market in June 2024, launching to U.S. consumers in September ((MedTech Dive)). Lingo is built on Abbott's FreeStyle Libre biosensor, which has been deployed in Europe as a wellness CGM since 2022 — so the device itself is more mature than its U.S. launch date suggests.

The framing is metabolic optimization rather than disease management. Lingo's app scores you on "glucose spikes," coaches you toward flatter curves, and integrates with workout and nutrition tracking. It's CGM as quantified-self gadget, not CGM as medical adjunct.

Pros
- 1-minute readings — 15x Stelo's data resolution, critical for catching spike peaks
- Tiered pricing starting at $49 for a single sensor — lowest barrier to entry in the U.S. - Cheapest per-sensor cost via the $249 six-pack: roughly $41.50 per sensor
- Wellness-oriented app design with spike scoring and coaching

Cons
- No publicly disclosed MARD from Abbott — independent CGM testing pegs it at 9.3%
- 14-day wear, one day shorter than Stelo
- Subscription pricing is worse than the bulk buy — a quirk most buyers miss
- Less clinical-feeling report export

Pricing Breakdown

The interesting tension is that both companies push subscriptions as the "save money" path, and only one of them is telling the truth.

Stelo:
- 2-pack (one-time): $99 → $49.50/sensor
- Subscription: $89/month for 2 sensors → $44.50/sensor (subscription wins by $5)

Lingo:
- 1-pack: $49 → $49/sensor
- 2-pack: $89 → $44.50/sensor
- 6-pack: $249 → $41.50/sensor
- Subscription: $1,092/year for ~24 sensors → ~$45.50/sensor (subscription loses to the 6-pack by $4/sensor)

If you know you'll wear a Lingo continuously, the $249 Transform 6-pack is the smarter buy by about $96 a year versus the annual subscription. Lingo's marketing pushes the monthly option harder, but the math doesn't back it up.

Both devices are HSA and FSA eligible (stelo.com, hellolingo.com) — submit the receipt the same way you would for prescription glasses. The effective discount depends on your federal marginal tax bracket: 22% if you're in the $48,475–$103,350 single-filer band, up to 37% at the top bracket, per the IRS 2026 tax tables. For a typical buyer in the 24% bracket, the $249 Lingo 6-pack effectively costs $189.

How We Evaluated

This comparison uses published manufacturer specs (stelo.com, hellolingo.com), FDA clearance documents, independent accuracy testing, and aggregated user reporting from (CNN) and (MedTech Dive). Both devices were evaluated on five criteria: per-sensor cost over 30 days, published accuracy, reading frequency, wear time, and use-case fit (prediabetes, performance, weight loss). Affiliate disclosures and our broader methodology are at /how-we-evaluate/.

Verdict

Winner: Stelo, for the broad middle of the OTC CGM market. You get the better published accuracy figure, an extra day of wear per sensor, and an app organized around the question that matters most for prediabetic and pre-prediabetic adults — are my trends moving in the right direction? The 15-minute reading cadence is a real limitation if you're chasing the peak of a single meal, but for the day-over-day pattern recognition that drives the lifestyle changes most CGM buyers are after (sleep timing, post-dinner walking, swapping refined carbs), it's plenty.

Where Stelo separates from Lingo isn't only the MARD number itself — it's that Dexcom published one, submitted it to the FDA, and shipped a report that a clinician can actually read. Abbott has built the slicker app and the faster sensor, but it has not yet put a clinical accuracy figure on the table. For a device you're going to use to make decisions about your metabolic health, that disclosure gap matters more than the one-day difference in wear time.

Runner-up: Lingo, and it wins outright in one scenario — you are tracking acute responses where the shape of the curve matters more than the daily average: workout fueling, meal experiments, fasted training, or sleep-disruption events. Stelo's 15-minute resolution will miss the spike. Lingo's 1-minute resolution catches it. The $49 1-pack is also the lowest-stakes way to find out whether wearing a CGM is something you'll actually stick with.

If you're a prediabetic adult trying to understand whether the post-dinner walk actually works for you, buy Stelo. If you're an endurance athlete chasing a fueling strategy or someone curious about which specific foods spike you, buy Lingo's $49 Start kit first, then upgrade to the $249 six-pack if you're hooked.

The one place neither device belongs: insulin dosing. Both are restricted to adults 18+ not on insulin per FDA labeling, and using either to time bolus doses is off-label and unsafe. If you take insulin, you need a prescription G7 or FreeStyle Libre 3 — not an OTC device.

Found an error? At Canopy Press, accuracy comes first. If you spot a claim that needs checking, let us know at [email protected] — we'll verify and correct it immediately.

Sources

• Stelo by Dexcom — Official Site
• Lingo by Abbott — Official Site
• Dexcom Prices First Over-the-Counter Glucose Monitor — MedTech Dive
• Abbott Debuts Lingo Over-the-Counter CGM in the US — MedTech Dive
• Dexcom Announces Availability, Pricing of Stelo — HCPLive
• Dexcom Stelo vs Abbott Lingo 2026 — improve Biomarkers
• Lingo vs. Stelo Continuous Glucose Monitors — CNN Underscored
• Dexcom's Stelo, its first over-the-counter glucose monitor, hits the market — Fierce Biotech
• FDA — Continuous Glucose Monitors
• IRS — 2026 Tax Brackets

Some links are affiliate links — we may earn a commission if you sign up through them, at no extra cost to you. We only recommend products we've actually evaluated. See our editorial standards for more.

Found an error? At Canopy Press, accuracy comes first. If you spot a claim that needs checking, let us know at [email protected] — we'll verify and correct it immediately.